Moderate exercise delays the motor performance decline in a transgenic model of ALS

Brain Research

Volumn 1313, Issue , 2010, Pages 192-201

  Carreras, Isabel ^a,b   Yuruker, Sinan ^a,b,c   Aytan, Nurgul ^a,b   Hossain, Lokman ^b   Choi, Ji Kyung ^d   Jenkins, Bruce G ^d   Kowall, Neil W ^a,b   Dedeoglu, Alpaslan ^a,b,d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c HACETTEPE UNIVERSITY   (Turkey)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Amyotrophic lateral sclerosis; Exercise; Motor neuron; Stereological method

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

AGE DISTRIBUTION; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL COUNT; CELL DENSITY; CONTROLLED STUDY; DEATH; DISEASE MODEL; EXERCISE INTENSITY; GENE MUTATION; GENE OVEREXPRESSION; MALE; MOTONEURON; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SPINAL CORD VENTRAL HORN; THERAPY EFFECT; TRANSGENIC MOUSE; TREADMILL EXERCISE; WILD TYPE;

AGE OF ONSET; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BODY WEIGHT; CELL COUNT; DISEASE MODELS, ANIMAL; DYSKINESIAS; HUMANS; LUMBAR VERTEBRAE; MALE; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; MOTOR NEURONS; PHYSICAL CONDITIONING, ANIMAL; RANDOM ALLOCATION; SPINAL CORD; SUPEROXIDE DISMUTASE; TIME FACTORS;

MUS; MUS MUSCULUS;

EID: 74149088951     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.11.051     Document Type: Article

References (70)

1. Armon C. Sports and trauma in amyotrophic lateral sclerosis revisited. J. Neurol. Sci. 262 (2007) 45-53
2. Azzouz M., Ralph G.S., Storkebaum E., Walmsley L.E., Mitrophanous K.A., Kingsman S.M., Carmeliet P., and Mazarakis N.D. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429 (2004) 413-417
3. Bello-Haas V.D., Florence J.M., Kloos A.D., Scheirbecker J., Lopate G., Hayes S.M., Pioro E.P., and Mitsumoto H. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology 68 (2007) 2003-2007
4. Berchtold N.C., Chinn G., Chou M., Kesslak J.P., and Cotman C.W. Exercise primes a molecular memory for BDNF protein induction in the rat hippocampus. Neuroscience 133 (2005) 853-861
5. Biondi O., Grondard C., Lecolle S., Deforges S., Pariset C., Lopes P., Cifuentes-Diaz C., Li H., della Gaspera B., Chanoine C., and Charbonnier F. Exercise-induced activation of NMDA receptor promotes motor unit development and survival in a type 2 spinal muscular atrophy model mouse. J. Neurosci. 28 (2008) 953-962
6. Boillee S., Vande Velde C., and Cleveland D.W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52 (2006) 39-59
7. Bondy C.A., and Cheng C.M. Signaling by IGF-1 in brain. Eur. J. Pharmacol. 490 (2004) 25-31
8. Brown Jr. R.H. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 80 (1995) 687-692
9. Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S.S., Rothstein J.D., Borchelt D.R., Price D.L., and Cleveland D.W. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18 (1997) 327-338
10. Carro E., Spuch C., Trejo J.L., Antequera D., and Torres-Aleman I. Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I. J. Neurosci. 25 (2005) 10884-10893
11. Chio A., Benzi G., Dossena M., Mutani R., and Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain 128 (2005) 472-476
12. Choudry R.B., and Cudkowicz M.E. Clinical trials in ALS: the tenuous past and the promising future. J. Clin. Pharmacol. 45 (2005) 1334-1344
13. Cotman C.W., and Berchtold N.C. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci. 25 (2002) 295-301
14. Deforges S., Branchu J., Biondi O., Grondard C., Pariset C., Lecolle S., Lopes P., Vidal P.P., Chanoine C., and Charbonnier F. Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. J. Physiol. 587 (2009) 3561-3572
15. Ding Y.H., Li J., Zhou Y., Rafols J.A., Clark J.C., and Ding Y. Cerebral angiogenesis and expression of angiogenic factors in aging rats after exercise. Curr. Neurovasc. Res. 3 (2006) 15-23
16. Dobrowolny G., Giacinti C., Pelosi L., Nicoletti C., Winn N., Barberi L., Molinaro M., Rosenthal N., and Musaro A. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J. Cell. Biol. 168 (2005) 193-199
17. Dodge J.C., Haidet A.M., Yang W., Passini M.A., Hester M., Clarke J., Roskelley E.M., Treleaven C.M., Rizo L., Martin H., Kim S.H., Kaspar R., Taksir T.V., Griffiths D.A., Cheng S.H., Shihabuddin L.S., and Kaspar B.K. Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity. Mol. Ther. 16 (2008) 1056-1064
18. Dore S., Kar S., and Quirion R. Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases. Trends Neurosci. 20 (1997) 326-331
19. Drory V.E., Goltsman E., Reznik J.G., Mosek A., and Korczyn A.D. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 191 (2001) 133-137
20. Eadie B.D., Redila V.A., and Christie B.R. Voluntary exercise alters the cytoarchitecture of the adult dentate gyrus by increasing cellular proliferation, dendritic complexity, and spine density. J. Comp. Neurol. 486 (2005) 39-47
21. Engesser-Cesar C., Anderson A.J., Basso D.M., Edgerton V.R., and Cotman C.W. Voluntary wheel running improves recovery from a moderate spinal cord injury. J. Neurotrauma. 22 (2005) 157-171
22. Engesser-Cesar C., Anderson A.J., and Cotman C.W. Wheel running and fluoxetine antidepressant treatment have differential effects in the hippocampus and the spinal cord. Neuroscience 144 (2007) 1033-1044
23. Fabel K., Tam B., Kaufer D., Baiker A., Simmons N., Kuo C.J., and Palmer T.D. VEGF is necessary for exercise-induced adult hippocampal neurogenesis. Eur. J. Neurosci. 18 (2003) 2803-2812
24. Farmer J., Zhao X., van Praag H., Wodtke K., Gage F.H., and Christie B.R. Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male Sprague-Dawley rats in vivo. Neuroscience 124 (2004) 71-79
25. Felmus M.T., Patten B.M., and Swanke L. Antecedent events in amyotrophic lateral sclerosis. Neurology 26 (1976) 167-172
26. Ferrante R.J., Klein A.M., Dedeoglu A., and Beal M.F. Therapeutic efficacy of EGb761 (Gingko biloba extract) in a transgenic mouse model of amyotrophic lateral sclerosis. J. Mol. Neurosci. 17 (2001) 89-96
27. Ferrara N. Vascular endothelial growth factor. Eur. J. Cancer. 32A (1996) 2413-2422
28. Gregoire N., and Serratrice G. Risk factors in amyotrophic lateral sclerosis. Initial results apropos of 35 cases. Rev. Neurol. (Paris) 147 (1991) 706-713
29. Grondard C., Biondi O., Armand A.S., Lecolle S., Della Gaspera B., Pariset C., Li H., Gallien C.L., Vidal P.P., Chanoine C., and Charbonnier F. Regular exercise prolongs survival in a type 2 spinal muscular atrophy model mouse. J. Neurosci. 25 (2005) 7615-7622
30. Gruzman A., Wood W.L., Alpert E., Prasad M.D., Miller R.G., Rothstein J.D., Bowser R., Hamilton R., Wood T.D., Cleveland D.W., Lingappa V.R., and Liu J. Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 12524-12529
31. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
32. Hutchinson K.J., Gomez-Pinilla F., Crowe M.J., Ying Z., and Basso D.M. Three exercise paradigms differentially improve sensory recovery after spinal cord contusion in rats. Brain 127 (2004) 1403-1414
33. Kaspar B.K., Llado J., Sherkat N., Rothstein J.D., and Gage F.H. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301 (2003) 839-842
34. Kaspar B.K., Frost L.M., Christian L., Umapathi P., and Gage F.H. Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Ann. Neurol. 57 (2005) 649-655
35. Kirkinezos I.G., Hernandez D., Bradley W.G., and Moraes C.T. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann. Neurol. 53 (2003) 804-807
36. Kriz J., Gowing G., and Julien J.P. Efficient three-drug cocktail for disease induced by mutant superoxide dismutase. Ann. Neurol. 53 (2003) 429-436
37. Kurtzke J.F., and Beebe G.W. Epidemiology of amyotrophic lateral sclerosis: 1. A case-control comparison based on ALS deaths. Neurology 30 (1980) 453-462
38. Lepore A.C., Haenggeli C., Gasmi M., Bishop K.M., Bartus R.T., Maragakis N.J., and Rothstein J.D. Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS. Brain Res. 1185 (2007) 256-265
39. Leuner B., Gould E., and Shors T.J. Is there a link between adult neurogenesis and learning?. Hippocampus 16 (2006) 216-224
40. Liebetanz D., Hagemann K., von Lewinski F., Kahler E., and Paulus W. Extensive exercise is not harmful in amyotrophic lateral sclerosis. Eur. J. Neurosci. 20 (2004) 3115-3120
41. Longstreth W.T., Nelson L.M., Koepsell T.D., and van Belle G. Hypotheses to explain the association between vigorous physical activity and amyotrophic lateral sclerosis. Med. Hypotheses. 34 (1991) 144-148
42. Lopez-Lopez C., LeRoith D., and Torres-Aleman I. Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 9833-9838
43. Mahoney D.J., Rodriguez C., Devries M., Yasuda N., and Tarnopolsky M.A. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve 29 (2004) 656-662
44. McCrate M.E., and Kaspar B.K. Physical activity and neuroprotection in amyotrophic lateral sclerosis. Neuromol. Med. 10 (2008) 108-117
45. McCusker R.H., McCrea K., Zunich S., Dantzer R., Broussard S.R., Johnson R.W., and Kelley K.W. IGF-I enhances the biological activity of BDNF on cerebrocortical neurons. J. Neuroimmunol. 179 (2006) 186-190
46. Nagano I., Ilieva H., Shiote M., Murakami T., Yokoyama M., Shoji M., and Abe K. Therapeutic benefit of intrathecal injection of IGF-1 in a mouse model of ALS. J. Neurol. Sci. 235 (2005) 61-68
47. Narai H., Nagano I., Ilieva H., Shiote M., Nagata T., Hayashi T., Shoji M., and Abe K. Prevention of spinal motor neuron death by insulin-like growth factor-1 associating with the signal transduction systems in SODG93A transgenic mice. J. Neurosci. Res. 82 (2005) 452-457
48. Nirmalananthan N., and Greensmith L. ALS: recent advances and future therapies. Curr. Opin. Neurol. 18 (2005) 712-719
49. Oosthuyse B., Moons L., Storkebaum E., et al. Deletion of the hypoxia-response element in the VEGF promoter causes motor neuron degeneration. Nat. Genet. 28 (2001) 131-138
50. Pereira A.C., Huddleston D.E., Brickman A.M., Sosunov A.A., Hen R., McKhann G.M., Sloan R., Gage F.H., Brown T.R., and Small S.A. An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 5638-5643
51. Pinto A.C., Alves M., Nogueira A., Evangelista T., Carvalho J., Coelho A., de Carvalho M., and Sales-Luis M.L. Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise?. J. Neurol. Sci. 169 (1999) 69-75
52. Qureshi M.M., Hayden D., Urbinelli L., Ferrante K., Newhall K., Myers D., Hilgenberg S., Smart R., Brown R.H., and Cudkowicz M.E. Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotroph. Lateral Scler. 7 (2006) 173-182
53. Radak Z., Naito H., Kaneko T., Tahara S., Nakamoto H., Takahashi R., Cardozo-Pelaez F., and Goto S. Exercise training decreases DNA damage and increases DNA repair and resistance against oxidative stress of proteins in aged rat skeletal muscle. Pflugers Arch. 445 (2002) 273-278
54. Ramsden M., Berchtold N.C., Patrick Kesslak J., Cotman C.W., and Pike C.J. Exercise increases the vulnerability of rat hippocampal neurons to kainate lesion. Brain Res. 971 (2003) 239-244
55. Ripps M.E., Huntley G.W., Hof P.R., Morrison J.H., and Gordon J.W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 689-693
56. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
57. Scarmeas N., Shih T., Stern Y., Ottman R., and Rowland L.P. Premorbid weight, body mass, and varsity athletics in ALS. Neurology 59 (2002) 773-775
58. Schwarz A.J., Brasel J.A., Hintz R.L., Mohan S., and Cooper D.M. Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J. Clin. Endocrinol. Metab. 81 (1996) 3492-3497
59. Sorenson E.J., Windbank A.J., Mandrekar J.N., Bamlet W.R., Appel S.H., Armon C., Barkhaus P.E., Bosch P., Boylan K., David W.S., Feldman E., Glass J., Gutmann L., Katz J., King W., Luciano C.A., McCluskey L.F., Nash S., Newman D.S., Pascuzzi R.M., Pioro E., Sams L.J., Scelsa S., Simpson E.P., Subramony S.H., Tiryaki E., and Thornton C.A. Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology 71 (2008) 1770-1775
60. Storkebaum E., Lambrechts D., Dewerchin M., Moreno-Murciano M.P., Appelmans S., Oh H., Van Damme P., Rutten B., Man W.Y., De Mol M., Wyns S., Manka D., Vermeulen K., Van Den Bosch L., Mertens N., Schmitz C., Robberecht W., Conway E.M., Collen D., Moons L., and Carmeliet P. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci. 8 (2005) 85-92
61. Strickland D., Smith S.A., Dolliff G., Goldman L., and Roelofs R.I. Physical activity, trauma, and ALS: a case-control study. Acta Neurol. Scand. 94 (1996) 45-50
62. Trejo J.L., Carro E., and Torres-Aleman I. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J. Neurosci. 21 (2001) 1628-1634
63. van Praag H., Christie B.R., Sejnowski T.J., and Gage F.H. Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13427-13431
64. Vaynman S., Ying Z., and Gomez-Pinilla F. Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur. J. Neurosci. 20 (2004) 2580-2590
65. Vaynman S.S., Ying Z., Yin D., and Gomez-Pinilla F. Exercise differentially regulates synaptic proteins associated to the function of BDNF. Brain Res. 1070 (2006) 124-130
66. Veldink J.H., Bar P.R., Joosten E.A., Otten M., Wokke J.H., and van den Berg L.H. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul. Disord. 13 (2003) 737-743
67. Veldink J.H., Kalmijn S., Groeneveld G.J., Titulaer M.J., Wokke J.H., and van den Berg L.H. Physical activity and the association with sporadic ALS. Neurology 64 (2005) 241-245
68. von Bohlen und Halbach O., Minichiello L., and Unsicker K. TrkB but not trkC receptors are necessary for postnatal maintenance of hippocampal spines. Neurobiol Aging 29 (2008) 1247-1255
69. Winocur G., Wojtowicz J.M., Sekeres M., Snyder J.S., and Wang S. Inhibition of neurogenesis interferes with hippocampus-dependent memory function. Hippocampus 16 (2006) 296-304
70. Wu C.W., Chang Y.T., Yu L., Chen H.I., Jen C.J., Wu S.Y., Lo C.P., and Kuo Y.M. Exercise enhances the proliferation of neural stem cells and neurite growth and survival of neuronal progenitor cells in dentate gyrus of middle-aged mice. J. Appl. Physiol. 105 (2008) 1585-1594